Recurrent pericarditis: New and emerging therapeutic options

Nature Reviews Cardiology

Volumn 13, Issue 2, 2016, Pages 99-105

  Imazio, Massimo ^a   Lazaros, George ^b   Brucato, Antonio ^c   Gaita, Fiorenzo ^d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Azienda Ospedaliera di Bergamo   (Italy)

^d CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; HUMAN IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ANTIRHEUMATIC AGENT; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOLOGIC FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; PERICARDIECTOMY; PERICARDITIS; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; RECURRENT PERICARDITIS; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ASPIRIN; AZATHIOPRINE; COLCHICINE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; PERICARDITIS; RECURRENCE; TREATMENT OUTCOME;

EID: 84955349007     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2015.115     Document Type: Review

References (63)

1. Imazio, M., et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation 112, 2012-2016 (2005).
2. Imazio, M., et al. Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch. Intern. Med. 165, 1987-1991 (2005).
3. Imazio, M., et al. Colchicine for recurrent pericarditis (CORP): a randomized trial. Ann. Intern. Med. 155, 409-414 (2011).
4. Imazio, M., et al. A randomized trial of colchicine for acute pericarditis. N. Engl. J. Med. 369, 1522-1528 (2013).
5. Imazio, M., et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP 2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet 383, 2232-2237 (2014).
6. Artom, G., et al. Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis. Eur. Heart J. 26, 723-727 (2005).
7. Imazio, M., et al. Management, risk factors, and outcomes in recurrent pericarditis. Am. J. Cardiol. 96, 736-739 (2005).
8. Seferovic, P. M., et al. Pericardial syndromes: an update after the ESC guidelines 2004. Heart Fail. Rev. 18, 255-266 (2013).
9. Maisch, B., Rupp, H., Ristic, A. & Pankuweit, S. Pericardioscopy and epi-and pericardial biopsy-A new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy. Heart Fail. Rev. 18, 317-328 (2013).
10. LeWinter, M. M. Clinical practice. Acute pericarditis. N. Engl. J. Med. 371, 2410-2416 (2014).
11. Brucato, A., et al. Recurrent pericarditis: infectious or autoimmune? Autoimmun. Rev. 8, 44-47 (2008).
12. Cantarini, L., et al. Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin. Rev. Allergy Immunol. 44, 6-13 (2013).
13. Imazio, M. Idiopathic recurrent pericarditis as an immune-mediated disease: current insights into pathogenesis and emerging treatment options. Expert Rev. Clin. Immunol. 11, 1487-1492 (2014).
14. Imazio, M., et al. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. Int. J. Cardiol. 136, 289-293 (2009).
15. Caforio, A. L., et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart 96, 779-784 (2010).
16. Imazio, M. Pericardial involvement in systemic inflammatory diseases. Heart 97, 1882-1892 (2011).
17. Imazio, M., Hoit, B. D. Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int. J. Cardiol. 168, 648-652 (2013).
18. Imazio, M., Adler, Y. Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis. Heart Fail. Rev. 18, 355-360 (2013).
19. Brucato, A., Brambilla, G. Recurrent idiopathic pericarditis: familial occurrence. Int. J. Cardiol. 102, 529 (2005).
20. Soriano, A., Manna, R. Familial Mediterranean fever: new phenotypes. Autoimmun. Rev. 1, 31-37 (2012).
21. Cantarini, L., et al. Clues to detect tumor necrosis factor receptor-Associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study. Clin. Res. Cardiol. 101, 525-531 (2012).
22. Cantarini, L., Lucherini, O. M., Baldari, C. T., Laghi Pasini, F. & Galeazzi, M. Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-Associated periodic syndrome. Clin. Exp. Rheumatol. 28, 405-407 (2010).
23. Cantarini, L., et al. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-Associated periodic syndrome. Int. J. Immunopathol. Pharmacol. 22, 1051-1058 (2009).
24. Maisch, B. Recurrent pericarditis: mysterious or not so mysterious? Eur. Heart J. 26, 631-633 (2005).
25. Imazio, M., et al. Relation of acute pericardial disease to malignancy. Am. J. Cardiol. 95, 1393-1394 (2005).
26. Imazio, M., et al. Medical therapy of pericardial diseases: part II: noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J. Cardiovasc. Med. (Hagerstown) 11, 785-794 (2010).
27. Imazio, M., et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J. Cardiovasc. Med. (Hagerstown) 10, 217-230 (2009).
28. Seidenberg, P. H. & Haynes, J. Pericarditis: diagnosis, management, and return to play. Curr. Sports Med. Rep. 5, 74-79 (2006).
29. Soler-Soler, J., Sagristà-Sauleda, J. & Permanyer-Miralda, G. Relapsing pericarditis. Heart 90, 1364-1368 (2004).
30. Klein, A. L., et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J. Am. Soc. Echocardiogr. 26, 965-1012.e15 (2013).
31. Alraies, M. C., et al. Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. Am. J. Cardiol. 115, 542-547 (2014).
32. Young, P. M., et al. MR imaging findings in 76 consecutive surgically proven cases of pericardial disease with CT and pathologic correlation. Int. J. Cardiovasc. Imaging 28, 1099-2010 (2012).
33. Cremer, P. C. & Kwon, D. H. Multimodality imaging of pericardial disease. Curr. Cardiol. Rep. 17, 24 (2015).
34. Imazio, M. & Gaita, F. Diagnosis and treatment of pericarditis. Heart 101, 1159-1168 (2015).
35. Imazio, M., et al. Recurrent pain without objective evidence of disease in patients with previous idiopathic or viral acute pericarditis. Am. J. Cardiol. 94, 973-975 (2004).
36. Horneffer, P. J., et al. The effective treatment of postpericardiotomy syndrome after cardiac operations. A randomized placebo-controlled trial. J. Thorac. Cardiovasc. Surg. 100, 292-296 (1990).
37. Lotrionte, M., et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am. Heart J. 160, 662-670 (2010).
38. Imazio, M., Brucato, A., Trinchero, R., Spodick, D. & Adler, Y. Individualized therapy for pericarditis. Expert Rev. Cardiovasc. Ther. 7, 965-975 (2009).
39. Maisch, B., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur. Heart J. 25, 587-610 (2004).
40. Imazio, M., et al. Prevalence of C reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation 123, 1092-1097 (2011).
41. Imazio, M., et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation 118, 667-671 (2008).
42. Ristic, A. D., et al. Pericardial disease in pregnancy. Herz 28, 209-215 (2003).
43. Imazio, M., et al. Management of pericardial diseases during pregnancy. J. Cardiovasc. Med. (Hagerstown) 11, 557-562 (2010).
44. Imazio, M. New clinical trials in acute and recurrent pericarditis. Curr. Cardiol. Rep. 17, 23 (2015).
45. Rodriguez de la Serna, A., Guindo Soldevila, J., Marti Claramunt, V. & Bayés de Luna, A. Colchicine for recurrent pericarditis. Lancet 2, 1517 (1987).
46. Adler, Y., et al. Colchicine treatment for recurrent pericarditis. A decade of experience. Circulation 97, 2183-2185 (1998).
47. Imazio, M. Colchicine for pericarditis. Trends Cardiovasc. Med. 25, 129-136 (2015).
48. Briasoulis, A. & Afonso, L. Prevention of pericarditis with colchicine: an updated meta-Analysis. J. Cardiovasc. Med. (Hagerstown) 16, 144-147 (2015).
49. Alabed, S., Cabello, J. B., Irving, G. J., Qintar, M. & Burls, A. Colchicine for pericarditis. Cochrane Database of Systematic Reviews, Issue 8. Art. No.: CD010652. http://dx.doi.org/10.1002/14651858. CD010652.pub2.
50. Vianello, F., et al. Azathioprine in isolated recurrent pericarditis: a single centre experience. Int. J. Cardiol. 147, 477-478 (2011).
51. Gelfand, E. W. Intravenous immune globulin in autoimmune and inflammatory diseases. N. Engl. J. Med. 367, 2015-2025 (2012).
52. del Fresno, M. R., et al. Intravenous immunoglobulin therapy for refractory recurrent pericarditis. Pediatrics 134, e1441-E1446 (2014).
53. Moretti, M., et al. Usefulness of high-Dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. Am. J. Cardiol. 112, 1493-1498 (2013).
54. Imazio, M., et al. Intravenous human immunoglobulins for refractory recurrent pericarditis. A systematic review of all published cases. J. Cardiovasc. Med. (Hagerstown) http://dx.doi.org/10.2459/ JCM.0000000000000260.
55. Grattagliano, I., et al. Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics. Clin. Pharmacol. Ther. 95, 89-97 (2014).
56. Mertens, M. & Singh, J. A. Anakinra for rheumatoid arthritis: a systematic review. J. Rheumatol. 36, 1118-1125 (2009).
57. Picco, P., et al Successful treatment of idiopathic recurrent pericarditis in children with interleukin 1β receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum. 60, 264-268 (2009).
58. Lazaros, G., et al. Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases. Ann. Rheum. Dis. 73, 2215-2217 (2014).
59. Lazaros, G., et al. Anakinra: an emerging option for refractory idiopathic recurrent pericarditis. A systematic review of published evidence. J. Cardiovasc. Med. (Hagerstown) http://dx.doi. org/10.2459/JCM.0000000000000266.
60. Nieto González, J. C., et al. Idiopathic recurrent pericarditis treated successfully with tumour necrosis factor alpha blocking agents (anti TNF α). Clin. Exp. Rheumatol. 31, 776-778 (2013).
61. Khandaker, M. H., et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin. Proc. 87, 1062-1070 (2012).
62. Imazio, M., et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am. J. Cardiol. 100, 1026-1028 (2007).
63. Imazio, M., et al. Risk of constrictive pericarditis after acute pericarditis. Circulation 124,1270-1275 (2011).